Abstract
Neuroimaging is critical in the diagnosis of vascular cognitive impairment (VCI), due to the visualization of ischemic or hemorrhagic injury in the brain. For large vessel diseases, neuroimaging plays a supporting role by identifying the type (hemorrhagic vs. nonhemorrhagic) and localizing the site of the blocked vessel and the affected brain parenchyma. Magnetic resonance imaging (MRI) with magnetic resonance angiography (MRA) is a very sensitive tool in confirming the size and location of the symptomatic as well as asymptomatic strokes. For the small vessel diseases (SVD), neuroimaging plays an important role in diagnosing SVD since clinical course in SVD is slowly progressive without stepwise decline. Neuroimaging can be used to detect changes in the brain even before the symptoms are clinically evident in patients with VCI. MRI becomes the key neuroimaging modality and is preferred over computed tomography for research and clinical use owing to its high sensitivity. Characteristic features related to SVD detected by MRI include recent small subcortical infarcts, lacunes, white matter hyperintensities (WMH), perivascular spaces (PVS), and cerebral microbleeds (CMB). For example, T2-weighted images show old infarcts, fluid-attenuated inversion recovery (FLAIR) images reveal white matter changes and lacunar infarcts, and T2∗-weighted or susceptibility-weighted images reveal CMB. This chapter describes classical neuroimaging markers for VCI as detected by MRI, their relationships with cognition, and introduces recommended standard neuroimaging protocols for VCI (Standards for Reporting Vascular changes on Neuroimaging, STRIVE).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bowler J, Hachinski V. Vascular cognitive impairment: a new approach to vascular dementia. Baillieres Clin Neurol. 1995;4(2):357–76.
Banerjee G, Wilson D, Jäger HR, et al. Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment. Biochim Biophys Acta. 2016;1862(5):926–38.
Jeong JH, Kim EJ, Seo SW, et al. Cognitive and behavioral abnormalities of vascular cognitive impairment. In: Miller BL, Boeve BF, editors. The behavioral neurology of dementia. Cambridge: Cambridge University Press; 2016. p. 301–30.
Heiss WD, Rosenberg GA, Thiel A, et al. Neuroimaging in vascular cognitive impairment: a state-of-the-art review. BMC Med. 2016;14(1):174.
McKay E, Counts SE. Multi-infarct dementia: a historical perspective. Dement Geriatr Cogn Dis Extra. 2017;7(1):160–71.
Vitali P, Migliaccio R, Agosta F, et al. Neuroimaging in dementia. Semin Neurol. 2008;28(4):467–83.
Brainin M, Tuomilehto J, Heiss WD, et al. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol. 2015;22(2):229–38.
Kanekar S, Poot JD. Neuroimaging of vascular dementia. Radiol Clin N Am. 2014;52(2):383–401.
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–60.
Eizaguirre N, Rementeria G, González-Torres M, et al. Updates in vascular dementia. Heart Mind. 2017;1(1):22–35.
De Reuck J, Sieben G, De Coster W, et al. Stroke pattern and topography of cerebral infarcts. Eur Neurol. 1981;20(5):411–5.
Erkinjuntti T. Types of multi-infarct dementia. Acta Neurol Scand. 1987;75(6):391–9.
Erkinjuntti T, Sawada T, Whitehouse PJ. The Osaka conference on vascular dementia 1998. Alzheimer Dis Assoc Disord. 1999;13:S1–3.
Guermazi A, Miaux Y, Rovira-Cañellas A, et al. Neuroradiological findings in vascular dementia. Neuroradiology. 2007;49(1):1–22.
Momjian-Mayor I, Baron JC. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke. 2005;36(3):567–77.
Mangla R, Kolar B, Almast J, et al. Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics. 2011;31(5):1201–14.
Ferro JM. Hyperacute cognitive stroke syndromes. J Neurol. 2001;248(10):841–9.
Pullicino PM, Caplan LR, Hommel M, et al. Cerebral small artery disease: Advances in neurology, vol. 62. New York: Raven Press; 1993.
Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol. 1993;34(4):566–73.
Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol. 2012;8(4):189–202.
Fujioka M, Nishio K, Miyamoto S, et al. Hippocampal damage in the human brain after cardiac arrest. Cerebrovasc Dis. 2000;10(1):2–7.
Horstmann A, Frisch S, Jentzsch RT, et al. Resuscitating the heart but losing the brain: brain atrophy in the aftermath of cardiac arrest. Neurology. 2010;74(4):306–12.
Lass P, Buscombe JR, Harber M, et al. Cognitive impairment in patients with renal failure is associated with multiple-infarct dementia. Clin Nucl Med. 1999;24(8):561–5.
Zuccala G, Onder G, Pedone C, et al. Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology. 2001;57(11):1986–92.
Antonelli Incalzi R, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease—a neuropsychological and spect study. J Neurol. 2003;250(3):325–32.
Alosco ML, Gunstad J, Jerskey BA, et al. The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease. Brain Behav. 2013;3(6):626–36.
Alosco ML, Spitznagel MB, Cohen R, et al. Reduced cerebral perfusion predicts greater depressive symptoms and cognitive dysfunction at a 1-year follow-up in patients with heart failure. Int J Geriatr Psychiatry. 2013;29(4):428–36.
Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483–97.
Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.
Doubal FN, Dennis MS, Wardlaw JM. Characteristics of patients with minor ischaemic strokes and negative MRI: a cross-sectional study. J Neurol Neurosurg Psychiatry. 2011;82(5):540–2.
Moreau F, Patel S, Lauzon ML, et al. Cavitation after acute symptomatic lacunar stroke depends on time, location, and MRI sequence. Stroke. 2012;43(7):1837–42.
Prins ND, Scheltens P, et al. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157–65.
Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28(3):652–9.
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.
Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011;82(2):126–35.
Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006;63(2):246–50.
de Laat KF, Tuladhar AM, van Norden AG, et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2011;134(Pt 1):73–83.
Poggesi A, Pracucci G, Chabriat H, et al. Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc. 2008;56(9):1638–43.
Boone KB, Miller BL, Lesser IM, et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect. Arch Neurol. 1992;49(5):549–54.
van Straaten EC, Scheltens P, Knol DL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia. Stroke. 2003;34(8):1907–12.
Price CC, Mitchell SM, Brumback B, et al. MRI-leukoaraiosis thresholds and the phenotypic expression of dementia. Neurology. 2012;79(8):734–40.
de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000;47(2):145–51.
Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61(10):1531–4.
Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–6.
Reed BR, Eberling JL, Mungas D. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61(10):1545–50.
Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128(Pt 9):2034–41.
Jokinen H, Gouw AA, Madureira S, et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology. 2011;76(22):1872–8.
Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol. 1998;245(2):116–22.
Ramirez J, Berezuk C, McNeely AA, et al. Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases. Cell Mol Neurobiol. 2016;36(2):289–99.
Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450–4.
Potter GM, Doubal FN, Jackson CA, et al. Enlarged perivascular spaces and cerebral small vessel disease. Int J Stroke. 2015;10(3):376–81.
Zhu YC, Tzourio C, Soumare A, et al. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke. 2010;41(11):2483–90.
Zhu Y-C, Dufouil C, Soumaré A, et al. High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. J Alzheimers Dis. 2010;22(2):663–72.
Maclullich AM, Wardlaw JM, Ferguson KJ, et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry. 2004;75(11):1519–23.
Huijts M, Duits A, Staals J, et al. Basal ganglia enlarged perivascular spaces are linked to cognitive function in patients with cerebral small vessel disease. Curr Neurovasc Res. 2014;11(2):136–41.
Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165–74.
Seo SW, Lee BH, Kim E-J, et al. Clinical significance of microbleeds in subcortical vascular dementia. Stroke. 2007;38(6):1949–51.
van Es A, van der Grond J, de Craen A, et al. Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology. 2011;77(15):1446–52.
Wahlund L-O, Bronge L, Savitcheva I, et al. Neuroimaging in vascular cognitive impairment: structural and functional imaging in vascular dementia. In: Filippi M, editor. Oxford textbook of neuroimaging. Oxford: Oxford University Press; 2015. p. 200–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Kim, G.H., Hwang, J., Jeong, J.H. (2020). Classical Neuroimaging Biomarkers of Vascular Cognitive Impairment. In: Lee, SH., Lim, JS. (eds) Stroke Revisited: Vascular Cognitive Impairment. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1433-8_9
Download citation
DOI: https://doi.org/10.1007/978-981-10-1433-8_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1432-1
Online ISBN: 978-981-10-1433-8
eBook Packages: MedicineMedicine (R0)